Loading BIB detail
BIB targets 2x the DAILY move of the Nasdaq Biotechnology Index (NBI) by using a mix of equities, derivatives, and cash-like instruments, then resetting that exposure every day. It’s a leveraged, sector-specific tool focused on Nasdaq-listed biotech and pharma companies, with weights driven mainly by market cap and periodic index rebalances.
This fund is like a “double-speed” version of a Nasdaq biotech/pharma basket for one day at a time. You don’t just own regular stocks here—you also own a strategy that uses derivatives to try to deliver 2x the index’s daily move.
Loading chart...
2.00x leverage. Resets daily. Designed for short-term trading.
Showing the largest holdings by weight in BIB
| Logo | Ticker | ETF Weight | Market Value | |
|---|---|---|---|---|
NE | Net Other Assets (Liabilities) | Net Other Assets (Liabilities) | 33.17% | $27.1M |
GI | GILD GILEAD SCIENCES INC | GILEAD SCIENCES INC | 5.21% | $4.3M |
AM | AMGN AMGEN INC | AMGEN INC | 5.00% | $4.1M |
VR | VRTX VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC | 4.91% | $4.0M |
RE | REGN REGENERON PHARMACEUTICALS | REGENERON PHARMACEUTICALS | 4.23% | $3.5M |
AL | ALNY ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC | 2.26% | $1.8M |
IN | INSM INSMED INC | INSMED INC | 1.82% | $1.5M |
BI | BIIB BIOGEN INC | BIOGEN INC | 1.38% | $1.1M |
UT | UTHR UNITED THERAPEUTICS CORP | UNITED THERAPEUTICS CORP | 1.34% | $1.1M |
AR | ARGX ARGENX SE - ADR | ARGENX SE - ADR | 1.20% | $985.4K |
Breakdown of BIB by sector weightings (%)
Loading charts...
Top countries by weight (%)
Loading charts...